Nature Communications (May 2018)
Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease
- Masayoshi Ohkuro,
- Jun-Dal Kim,
- Yoshikazu Kuboi,
- Yuki Hayashi,
- Hayase Mizukami,
- Hiroko Kobayashi-Kuramochi,
- Kenzo Muramoto,
- Manabu Shirato,
- Fumiko Michikawa-Tanaka,
- Jun Moriya,
- Teruya Kozaki,
- Kazuma Takase,
- Kenichi Chiba,
- Kishan Lal Agarwala,
- Takayuki Kimura,
- Makoto Kotake,
- Tetsuya Kawahara,
- Naoki Yoneda,
- Shinsuke Hirota,
- Hiroshi Azuma,
- Nobuko Ozasa-Komura,
- Yoshiaki Ohashi,
- Masafumi Muratani,
- Keiji Kimura,
- Ieharu Hishinuma,
- Akiyoshi Fukamizu
Affiliations
- Masayoshi Ohkuro
- Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba
- Jun-Dal Kim
- Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba
- Yoshikazu Kuboi
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Yuki Hayashi
- Graduate School of Life and Environmental Sciences, University of Tsukuba
- Hayase Mizukami
- Graduate School of Life and Environmental Sciences, University of Tsukuba
- Hiroko Kobayashi-Kuramochi
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Kenzo Muramoto
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Manabu Shirato
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Fumiko Michikawa-Tanaka
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Jun Moriya
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Teruya Kozaki
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Kazuma Takase
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Kenichi Chiba
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Kishan Lal Agarwala
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Takayuki Kimura
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Makoto Kotake
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Tetsuya Kawahara
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Naoki Yoneda
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Shinsuke Hirota
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Hiroshi Azuma
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Nobuko Ozasa-Komura
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Yoshiaki Ohashi
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Masafumi Muratani
- Department of Genome Biology, Graduate School of Comprehensive Human Sciences and Faculty of Medicine, University of Tsukuba
- Keiji Kimura
- Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba
- Ieharu Hishinuma
- Tsukuba Research Laboratories, Eisai Co., Ltd.
- Akiyoshi Fukamizu
- Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba
- DOI
- https://doi.org/10.1038/s41467-018-04420-4
- Journal volume & issue
-
Vol. 9,
no. 1
pp. 1 – 10
Abstract
Inflammatory bowel disease (IBD) is initiated by integrins-mediated leukocyte adhesion to the activated colonic microvascular endothelium. Here, the authors show that inhibition of the calreticulin binding to integrin α subunits ameliorates the severity of IBD in animal models.